Intelligence Platform
Patents
Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12084438
GCN2 inhibitors and uses thereof
granted patentUS 12083113
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted patentUS 12084447
SHP2 phosphatase inhibitors and methods of use thereof
granted patentUS 12083141
Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
granted patentUS 12077605
Cysteine protease inhibitors and methods of use thereof
granted patentUS 12077506
Indane derivatives as hypoxia inducible factor-2(Ξ±) inhibitors
granted patentUS 12077515
Selective histone deacetylase inhibitors for the treatment of human disease
granted patentUS 12076324
Cancer treatments using combinations of CDK and ERK inhibitors
granted patentUS 12071428
Indazole compounds as kinase inhibitors
granted patentUS 12071438
Crystal forms of an ALK2 inhibitor
granted patentUS 12071411
Inhibitors of HIF-2Ξ± and methods of use thereof
granted patentUS 12070460
Methods of treating skin cancer with Carboxypeptidase Vitellogenic Like (CPVL) inhibitors
granted patentUS 12065448
Heteroaryl plasma kallikrein inhibitors
granted patentUS 12059418
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted patentUS 12060396
Fused in sarcoma (FUS) nuclear translocation inhibitors for preventing fibrosis
granted patentUS 12060555
MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis
granted patentUS 12060362
Inhibitors of glucose transporters (GLUTs)
granted patentUS 12060346
Inhibitors of APOL1 and methods of using same
granted patentUS 12054492
Imidazole-containing inhibitors of ALK2 kinase
granted patentUS 12054475
Substituted heterocycles as aldehyde dehydrogenase inhibitors
granted patentUS 12054500
Arginase inhibitors
granted patentUS 12054483
Small molecule inhibitors of DYRK/CLK and uses thereof
granted patentUS 12048749
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
granted patentUS 12043610
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement
granted